Molecular imaging of tumor hypoxia with positron emission tomography OJ Kelada, DJ Carlson Radiation research 181 (4), 335-349, 2014 | 53 | 2014 |
Event-by-event continuous respiratory motion correction for dynamic PET imaging Y Yu, C Chan, T Ma, Y Liu, JD Gallezot, M Naganawa, OJ Kelada, ... Journal of Nuclear Medicine 57 (7), 1084-1090, 2016 | 44 | 2016 |
High single doses of radiation may induce elevated levels of hypoxia in early-stage non-small cell lung cancer tumors OJ Kelada, RH Decker, SK Nath, KL Johung, MQ Zheng, Y Huang, ... International Journal of Radiation Oncology* Biology* Physics 102 (1), 174-183, 2018 | 40 | 2018 |
Integrating small animal irradiators with functional imaging for advanced preclinical radiotherapy research M Ghita, KH Brown, OJ Kelada, EE Graves, KT Butterworth Cancers 11 (2), 170, 2019 | 26 | 2019 |
Synthesis of [18F] FMISO in a flow-through microfluidic reactor: Development and clinical application MQ Zheng, L Collier, F Bois, OJ Kelada, K Hammond, J Ropchan, ... Nuclear Medicine and Biology 42 (6), 578-584, 2015 | 24 | 2015 |
Glypican-3-targeted alpha particle therapy for hepatocellular carcinoma MM Bell, NT Gutsche, AP King, KE Baidoo, OJ Kelada, PL Choyke, ... Molecules 26 (1), 4, 2020 | 22 | 2020 |
Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen … OJ Kelada, S Rockwell, MQ Zheng, Y Huang, Y Liu, CJ Booth, RH Decker, ... Molecular imaging and biology 19, 893-902, 2017 | 17 | 2017 |
Erythropoietin-stimulating agents and clinical outcomes in metastatic breast cancer patients with chemotherapy-induced anemia: a closed debate? O Kelada, L Marignol Tumor Biology 35, 5095-5100, 2014 | 13 | 2014 |
In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and Potency RM Berman, OJ Kelada, NT Gutsche, R Natarajan, RE Swenson, Y Fu, ... Cancer Biotherapy & Radiopharmaceuticals 34 (8), 498-503, 2019 | 10 | 2019 |
ImmunoPET as stoichiometric sensor for glypican-3 in models of hepatocellular carcinoma OJ Kelada, NT Gutsche, M Bell, RM Berman, KE Baidoo, BM Warner, ... International Journal of Radiation Oncology, Biology, Physics 108 (3), S180-S181, 2020 | 4 | 2020 |
Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption NA Virani, OJ Kelada, S Kunjachan, A Detappe, J Kwon, J Hayashi, ... Plos one 15 (7), e0236245, 2020 | 4 | 2020 |
Best practices for preclinical 18F-FDG PET imaging O Kelada, JC Tseng, J Peterson Journal of Nuclear Medicine 59 (supplement 1), 1155-1155, 2018 | 2 | 2018 |
Tumor hypoxia and radiotherapy OJ Kelada, DJ Carlson Tumor hypoxia. New Jersey: World Scientific, 1-48, 2016 | 2 | 2016 |
Serial imaging of tumor hypoxia in early stage non-small cell lung cancer patients undergoing stereotactic body radiotherapy O Kelada, RH Decker, M Zheng, Y Huang, Y Xia, J Gallezot, C Liu, ... International Journal of Radiation Oncology, Biology, Physics 90 (1), S26-S27, 2014 | 1 | 2014 |
A prototype for a machine-learning assisted image analysis tool for preclinical in vivo studies AM Aji, TM Kierski, JD Rojas, H Morilak, OJ Kelada, KH Gessner, ... Cancer Research 84 (6_Supplement), 2336-2336, 2024 | | 2024 |
Evaluation of Right Ventricular Function in Experimental Pulmonary Arterial Hypertension with 2d Semi-Quantitative and 3d Quantitative Volumetric Approach A Belenkov, B Kojonazarov, RT Schermuly, O Kelada, J Hostens A57. PULMONARY VASCULAR DISEASES AND RV FUNCTIONS: NOVEL SIGNALLING …, 2020 | | 2020 |
Noninvasive imaging of tumor hypoxia during radiation-induced tumor vascular disruption OJ Kelada, S Kunjachan, NA Virani, A Detappe, J Hayashi, T Ireland, ... Cancer Research 79 (13_Supplement), 85-85, 2019 | | 2019 |
Integrating Small Animal Irradiators withFunctional Imaging for Advanced Preclinical M Ghita, KH Brown, OJ Kelada Cancers, 11 (2), 2019 | | 2019 |
Conflict of interest statements OJ Kelada, RH Decker, SK Nath, KL Johung, MQ Zheng, Y Huang, ... | | 2018 |
Quantification of Tumor Hypoxia with Positron Emission Tomography in Preclinical Models and Patients OJ Kelada | | 2016 |